ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
IDEAYA Biosciences Submits IND Application for MAT2A Development Candidate IDE397
January 15, 2021IDEAYA Biosciences has submitted an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) for the initiation of a Phase 1 clinical trial to evaluate IDE397, a small molecule methionine adenosyltransferase 2a ... -
GSK and IDEAYA partner in synthetic lethality
June 18, 2020GlaxoSmithKline and IDEAYA Biosciences have announced a strategic partnership in synthetic lethality, an emerging arm of oncology and a core research focus for GSK.
Pharma Sources Insight January 2025
